AstraZeneca PLC(AZN) in fiscal 2022 has six reportable products sales: Oncology($14.6 billion ), Cardiovascular, Renal & Metabolism($9.18 billion ), Respiratory & Immunology($5.76 billion ), Vaccines & Immune Therapies($4.7 billion ), Rare Disease ($7 billion )and other($1.6 billion ).   Profitability analysis AstraZeneca PLC(AZN) reported total revenues of $44.3 billion, $37.4 billion and $26.6 billion in 2022,in…